Global Life Sciences Trends and Opportunities 2012-2015

NEW YORK, April 2, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Life Sciences Trends and Opportunities 2012-2015
http://www.reportlinker.com/p01075843/Global-Life-Sciences-Trends-and-Opportunities-2012-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Frost & Sullivan's global life sciences team analyzes the impact of important changes and key trends across the total pharmaceutical/biotechnology, diagnostics, and life sciences research industries. This research deliverable captures the global life sciences trends and opportunities for the period of 2012-2015, as supported by Frost & Sullivan's proprietary research and leading industry experts. Our global life sciences team is uniquely positioned to provide comprehensive analysis and guidance in the converging landscape. Topics include generics and biosimilars, emerging markets, pharmaceutical outsourcing, novel therapeutics, next generation diagnostics, research and development laboratories, and clinical laboratories.

TABLE OF CONTENTS

Executive Summary 6
Daunting Challenges for the Pharmaceutical Industry 12
Pharma's New Growth Strategies 17
Curbing the Costs of Drug Development 32
Lean Laboratories—Doing More With Less 37
Novel Biomarker Discovery Leading to Novel Therapeutics 41
Genetic Technologies are Integral to Healthcare 47
Conclusions 52
Appendix 55
The Frost & Sullivan Story 65

List of Exhibits
Life Sciences Trends and Opportunities: Executive Summary, Global, 2012-2015 7
Life Sciences Trends and Opportunities: Growth Areas Now and Developing, Global, 2012-2015 8
Life Sciences Trends and Opportunities: Companies to Watch, Global, 2012-2015 9
Life Sciences Trends and Opportunities: Competitive Companies Tracked by Frost & Sullivan, Global, 2012 10
Life Sciences Trends and Opportunities: Future Outlook for Healthcare Compared to Present, Global, 2012-2015 11
Life Sciences Trends and Opportunities: Key Mergers and Acquisitions by Pharmaceutical Companies, Global, 2010-2012 14
Life Sciences Trends and Opportunities: Open Innovation—Pfizer and Novartis, Global, 2011 24
Life Sciences Trends and Opportunities: Open Innovation—GlaxoSmithKline and Eli Lilly, Global, 2011 25
Life Sciences Trends and Opportunities: Healthcare Expenditure, Global, 2010-2020 26
Life Sciences Trends and Opportunities: Co-development Models, U.S., 2012 36
Non-Invasive Prenatal Testing Market: Level of Agreement that NIPT Should Replace Maternal Serum Screen, U.S., 2012 51
Life Sciences Trends and Opportunities: Patent Expirations for Major Drugs, U.S., 2011-2016 56
Life Sciences Trends and Opportunities: Patent Expirations for Top Biologics, U.S., 2011-2019 57
Life Sciences Trends and Opportunities: Top M&A Deals, U.S., 2011-2016 59

To order this report:
Global Life Sciences Trends and Opportunities 2012-2015

__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker